Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-14

FDA Approved: FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (CIPLA USA INC.)

View source ↗

Summary

FDA approved a supplemental application for the generic combination drug fosinopril sodium and hydrochlorothiazide (CIPLA USA INC.), expanding its availability …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosinopril Sodium and Hydrochlorothiazide (fosinopril sodium and hydrochlorothiazide)

Snippet

SUPPL AP for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE (FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE)